Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHCN)

Market Closed
19 Jun, 20:00
XMEX XMEX
MX$
85. 44
0
0%
MX$
71.23B Market Cap
- P/E Ratio
4% Div Yield
5,000 Volume
- Eps
MX$ 85.44
Previous Close
Add Transaction
Day Range
85.44 85.44
Year Range
85.44 152
Want to track BHCN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BHCN closed Friday higher at MX$85.44, an increase of 0% from Thursday's close, completing a monthly decrease of -34.2769% or -MX$44.56. Over the past 12 months, BHCN stock lost -32.7244%.
BHCN pays dividends to its shareholders, with the most recent payment made on Dec 22, 2010. The next estimated payment will be in 22 Dec 2010 on Dec 22, 2010 for a total of MX$1.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0364%, based on the last three reports.
Bausch Health Companies Inc. has completed 3 stock splits, with the recent split occurring on Oct 16, 2000.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BHCN Chart

People also search for

El Puerto de Liverpool, S.A.B. de C.V.
MX$ 101.33
-0.1872%
El Puerto de Liverpool S.A.B. de C.V.
MX$ 103.5
0%
LEA
Lear Corporation
MX$ 2,120
0%
Fibra Educativa
MX$ 53.9
0%
La Comer, S.A.B. de C.V.
MX$ 35.37
-1.5312%
Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?

Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock?

Zacks | 3 weeks ago
Bausch Health Companies Inc. (BHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Bausch Health Companies Inc. (BHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Bausch Health Companies Inc. (BHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Seekingalpha | 1 month ago
Bausch Health Companies Inc. (BHC) Presents at Barclays 30th Annual Leveraged Finance Conference 2026 Transcript

Bausch Health Companies Inc. (BHC) Presents at Barclays 30th Annual Leveraged Finance Conference 2026 Transcript

Bausch Health Companies Inc. (BHC) Presents at Barclays 30th Annual Leveraged Finance Conference 2026 Transcript

Seekingalpha | 1 month ago

Bausch Health Companies Inc. (BHCN) FAQ

What is the stock price today?

The current price is MX$85.44.

On which exchange is it traded?

Bausch Health Companies Inc. is listed on XMEX.

What is its stock symbol?

The ticker symbol is BHCN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4%.

What is its market cap?

As of today, the market cap is 71.23B.

Has Bausch Health Companies Inc. ever had a stock split?

Bausch Health Companies Inc. had 3 splits and the recent split was on Oct 16, 2000.

Bausch Health Companies Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Thomas J. Appio CEO
XMEX Exchange
CA0717341071 ISIN
CA Country
20,700 Employees
11 Jun 2014 Last Dividend
16 Oct 2000 Last Split
- IPO Date

Overview

Bausch Health Companies Inc. is a global player in the specialized pharmaceutical and medical device sector, with operations spanning both the United States and numerous other countries around the world. Its focus areas include gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. Originally known as Valeant Pharmaceuticals International, Inc., the company underwent a name change in July 2018, marking a new chapter in its history. Headquartered in Laval, Canada, the organization functions through five key segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb, each targeting specific market needs.

Products and Services

Bausch Health's diverse portfolio extends across various medical domains, including:

  • Gastroenterology: Under the Salix segment, the company provides innovative products aimed at gastrointestinal health, catering primarily to the US market.
  • International Pharmaceutical and Medical Devices: The International segment encompasses the distribution of branded and generic pharmaceuticals, OTC products, and aesthetic medical devices across different countries, focusing on meeting global health needs.
  • Aesthetic Medical Devices: Through the Solta Medical segment, Bausch Health engages in the development and sale of cutting-edge aesthetic devices, showcasing its commitment to advancing beauty and dermatological care.
  • Diversified Products: The Diversified segment offers a wide range of pharmaceuticals in neurology and various other therapeutic classes, including generic products, ortho dermatologic products, and dentistry products within the US. This diversification underscores the company's holistic approach to healthcare.
  • Vision Care and Ophthalmic Products: The Bausch + Lomb segment, named after the well-known eye health brand, provides a comprehensive line of products to address vision care, surgical requirements, and ophthalmic pharmaceutical needs, underlining Bausch Health's prominence in eye health solutions.

Contact Information

Address: 2150 St. ElzEar Boulevard West
Phone: 15147446792